Protagonist Therapeutics (PTGX) stock Forecast for 2021 – 2025

Protagonist Therapeutics (PTGX) stock Forecast for 2022 – 2026

Last update: January 27, 2023 (05:11)

Sector: Healthcare

The share price of Protagonist Therapeutics, Inc. (PTGX) now

What analysts predict: $33
52-week High/Low: $30.42 / $6.91

50/200 Day Moving Average: $9.38 / $9.95

This figure corresponds to the Average Price over the previous 50/200 days. For Protagonist Therapeutics stocks, the 50-day moving average is the support level today.

For Protagonist Therapeutics stocks, the 200-day moving average is the support level today.

Are you interested in Protagonist Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Protagonist Therapeutics stock price in 2023, 2024, 2025, 2026, 2027. How much will one Protagonist Therapeutics share be worth in 2023 - 2027?

When should I take profit in Protagonist Therapeutics stock? When should I record a loss on Protagonist Therapeutics stock? What are analysts' forecasts for Protagonist Therapeutics stock? What is the future of Protagonist Therapeutics stock? We forecast Protagonist Therapeutics stock performance using neural networks based on historical data on Protagonist Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Protagonist Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2023, 2024, 2025, 2026 and 2027) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Protagonist Therapeutics shares. This happens once a day.




Historical and forecast chart of Protagonist Therapeutics stock

The chart below shows the historical price of Protagonist Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Protagonist Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Protagonist Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
Jan 29 28.62 28.14 28.98 2.96
Jan 30 28.51 28.06 28.97 3.22
Jan 31 28.53 27.98 29.16 4.21
Feb 01 28.33 27.92 28.95 3.70
Feb 02 29.15 28.85 29.80 3.27
Feb 03 28.91 28.33 29.32 3.49
Feb 04 28.68 28.03 29.03 3.57
Feb 05 28.66 28.45 29.31 3.03
Feb 06 29.43 28.72 30.17 5.05
Feb 07 28.62 28.10 29.13 3.68
Feb 08 28.66 28.14 29.31 4.14
Feb 09 28.51 27.83 28.89 3.80
Feb 10 28.56 27.87 29.29 5.08
Feb 11 28.32 28.12 28.63 1.84
Feb 12 28.69 28.38 29.01 2.23
Feb 13 28.27 27.86 28.56 2.50
Feb 14 28.29 27.81 28.87 3.81
Feb 15 29.10 28.42 29.52 3.87
Feb 16 28.57 27.85 28.82 3.48
Feb 17 28.40 27.69 28.88 4.30
Feb 18 28.34 27.62 28.89 4.63
Feb 19 28.49 28.12 29.16 3.70
Feb 20 28.62 28.42 28.81 1.35
Feb 21 28.57 27.99 29.21 4.34
Feb 22 29.38 28.89 29.94 3.61
Feb 23 29.99 29.62 30.53 3.08
Feb 24 29.60 28.84 29.98 3.94
Feb 25 29.33 29.11 29.88 2.64
Feb 26 28.79 28.33 29.43 3.90
Feb 27 28.23 28.05 28.91 3.09

Protagonist Therapeutics Daily Price Targets


Protagonist Therapeutics Stock Forecast 01-29-2023.

Forecast target price for 01-29-2023: $28.62.
Negative dynamics for Protagonist Therapeutics shares will prevail with possible volatility of 2.876%.
Pessimistic target level: 28.14
Optimistic target level: 28.98

Protagonist Therapeutics Stock Forecast 01-30-2023.

Forecast target price for 01-30-2023: $28.51.
Negative dynamics for Protagonist Therapeutics shares will prevail with possible volatility of 3.118%.
Pessimistic target level: 28.06
Optimistic target level: 28.97

Protagonist Therapeutics Stock Forecast 01-31-2023.

Forecast target price for 01-31-2023: $28.53.
Positive dynamics for Protagonist Therapeutics shares will prevail with possible volatility of 4.039%.
Pessimistic target level: 27.98
Optimistic target level: 29.16

Protagonist Therapeutics Stock Forecast 02-01-2023.

Forecast target price for 02-01-2023: $28.33.
Negative dynamics for Protagonist Therapeutics shares will prevail with possible volatility of 3.569%.
Pessimistic target level: 27.92
Optimistic target level: 28.95

Protagonist Therapeutics Stock Forecast 02-02-2023.

Forecast target price for 02-02-2023: $29.15.
Positive dynamics for Protagonist Therapeutics shares will prevail with possible volatility of 3.162%.
Pessimistic target level: 28.85
Optimistic target level: 29.80

Protagonist Therapeutics Stock Forecast 02-03-2023.

Forecast target price for 02-03-2023: $28.91.
Negative dynamics for Protagonist Therapeutics shares will prevail with possible volatility of 3.376%.
Pessimistic target level: 28.33
Optimistic target level: 29.32

PTGX (PTGX) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Feb. 32.21 29.77 33.79 11.89
Mar. 30.55 28.79 32.71 11.99
Apr. 29.89 28.88 31.97 9.65
May. 28.63 26.98 31.00 12.97
Jun. 27.29 24.87 28.01 11.22
Jul. 29.22 27.05 31.40 13.85
Aug. 31.96 29.62 32.96 10.12
Sep. 31.11 29.51 33.47 11.83
Oct. 31.97 28.90 33.16 12.84
Nov. 29.48 28.17 31.71 11.16
Dec. 27.00 25.32 27.68 8.54

Protagonist Therapeutics forecast for this year


Protagonist Therapeutics Stock Prediction for Feb 2023

An uptrend is forecast for this month with an optimal target price of $32.2073. Pessimistic: $29.77. Optimistic: $33.79


Protagonist Therapeutics Stock Prediction for Mar 2023

An downtrend is forecast for this month with an optimal target price of $30.5454. Pessimistic: $28.79. Optimistic: $32.71


Protagonist Therapeutics Stock Prediction for Apr 2023

An downtrend is forecast for this month with an optimal target price of $29.8856. Pessimistic: $28.88. Optimistic: $31.97


Protagonist Therapeutics Stock Prediction for May 2023

An downtrend is forecast for this month with an optimal target price of $28.6304. Pessimistic: $26.98. Optimistic: $31.00


Protagonist Therapeutics Stock Prediction for Jun 2023

An downtrend is forecast for this month with an optimal target price of $27.2905. Pessimistic: $24.87. Optimistic: $28.01


Protagonist Therapeutics Stock Prediction for Jul 2023

An uptrend is forecast for this month with an optimal target price of $29.2227. Pessimistic: $27.05. Optimistic: $31.40


Protagonist Therapeutics Stock Prediction for Aug 2023

An uptrend is forecast for this month with an optimal target price of $31.9579. Pessimistic: $29.62. Optimistic: $32.96


Protagonist Therapeutics Stock Prediction for Sep 2023

An downtrend is forecast for this month with an optimal target price of $31.1142. Pessimistic: $29.51. Optimistic: $33.47


Protagonist Therapeutics Stock Prediction for Oct 2023

An uptrend is forecast for this month with an optimal target price of $31.973. Pessimistic: $28.90. Optimistic: $33.16


Protagonist Therapeutics Stock Prediction for Nov 2023

An downtrend is forecast for this month with an optimal target price of $29.4791. Pessimistic: $28.17. Optimistic: $31.71


Protagonist Therapeutics Stock Prediction for Dec 2023

An downtrend is forecast for this month with an optimal target price of $27.0028. Pessimistic: $25.32. Optimistic: $27.68



Protagonist Therapeutics (PTGX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 26.32 23.92 27.02 11.46
Feb 27.11 25.00 29.23 14.47
Mar 27.70 26.17 29.46 11.17
Apr 26.63 25.68 27.34 6.08
May 25.74 23.27 28.12 17.25
Jun 24.63 22.71 26.02 12.72
Jul 25.93 24.53 27.64 11.26
Aug 25.40 24.58 27.14 9.43
Sep 23.91 22.90 25.22 9.21
Oct 24.39 23.19 25.01 7.26
Nov 23.08 22.08 24.63 10.34
Dec 21.58 19.92 22.20 10.26

Protagonist Therapeutics (PTGX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 21.22 19.66 22.31 11.87
Feb 20.12 18.63 20.82 10.55
Mar 21.02 20.51 22.98 10.75
Apr 23.24 21.59 25.02 13.71
May 23.49 21.96 25.54 14.01
Jun 23.60 22.30 24.48 8.91
Jul 22.83 20.97 24.26 13.55
Aug 22.10 21.54 23.69 9.07
Sep 22.73 20.90 23.74 11.95
Oct 21.50 20.73 22.92 9.57
Nov 21.25 19.38 22.70 14.60
Dec 21.58 20.93 22.79 8.18

Protagonist Therapeutics (PTGX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 22.92 21.52 25.04 14.06
Feb 22.76 21.72 23.77 8.62
Mar 23.55 22.62 25.36 10.81
Apr 23.83 21.57 25.64 15.84
May 22.78 22.20 24.09 7.83
Jun 23.76 21.62 25.27 14.44
Jul 22.96 21.58 24.64 12.41
Aug 21.91 20.10 23.52 14.54
Sep 22.70 20.93 24.23 13.61
Oct 24.42 23.01 25.06 8.18
Nov 26.82 25.95 29.40 11.72
Dec 28.37 26.60 29.97 11.25

Protagonist Therapeutics (PTGX) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 28.95 26.27 30.89 14.96
Feb 27.42 26.36 28.57 7.72
Mar 28.47 26.69 29.97 10.94
Apr 27.58 25.56 29.04 11.97
May 24.54 23.77 26.66 10.82
Jun 25.07 22.87 25.73 11.11
Jul 23.44 22.12 24.85 10.98
Aug 21.53 20.08 22.87 12.20
Sep 22.33 21.71 22.89 5.15
Oct 23.11 21.55 23.83 9.54
Nov 24.83 22.71 27.00 15.89
Dec 23.60 22.33 24.48 8.79

Protagonist Therapeutics information and performance

“Protagonist Therapeutics, Inc.” is a clinical stage biopharmaceutical company with a peptide technology platform focused on the discovery and development of new chemical entities (NECs) to meet significant unmet medical needs. The Company’s product pipeline includes PTG-100, PTG-200 and PTG-300. His main focus is on the development of oral peptide formulations that target biological pathways, also targeting commercially available injectable antibodies. PTG-100 is an oral peptide product of an alpha-4-beta-7 (a4b7) integrin antagonist candidate who has completed a phase I clinical trial in normal healthy volunteers (NHVs). PTH-100 is being developed for the treatment of moderate to severe ulcerative colitis (UC). PTG-200 is an oral interleukin-23 (IL-23R) receptor antagonist being developed for the treatment of moderate to severe Crohn’s disease. PTG-300 is an injectable hepcidin mimetic for the treatment of rare conditions associated with iron overload.

Protagonist Therapeutics Address

7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, US

Market Capitalization: 573 653 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -130 860 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -2.581

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.621
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 5.84

Enterprise Value (EV) /Revenue

EV To EBITDA: -1.604

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 49198400

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.